These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 11198732)

  • 61. [The use of muscle relaxants for routine induction of anesthesia in Germany].
    Geldner G; Fuchs-Buder T; Hofmockel R; Diefenbach C; Ulm K; Blobner M
    Anaesthesist; 2003 May; 52(5):435-41. PubMed ID: 12750828
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
    Gätke MR; Bundgaard JR; Viby-Mogensen J
    Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Curare-like activity of decadonium diiodide].
    Kharkevich DA
    Farmakol Toksikol; 1970; 33(4):395-9. PubMed ID: 4261117
    [No Abstract]   [Full Text] [Related]  

  • 64. [Anesthesia in psychiatric ambulatory patients].
    Martínez-Corbalán Bey
    Rev Esp Anestesiol Reanim; 1970 Apr; 17(2):386-8. PubMed ID: 4249944
    [No Abstract]   [Full Text] [Related]  

  • 65. [Search for new antidepolarizing muscle relaxants and the 1st experience with their clinical use].
    Vanevskiĭ VL; Danilov AF; Kotomina GL; Malygin VV; Starshinova LA
    Anesteziol Reanimatol; 1978; (4):36-8. PubMed ID: 151518
    [No Abstract]   [Full Text] [Related]  

  • 66. The use of muscle relaxants in the intensive care unit.
    Sharpe MD
    Can J Anaesth; 1992 Nov; 39(9):949-62. PubMed ID: 1451224
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adrenocrotical function related to administration of muscle relaxants during halothane anesthesia in man.
    Matsuki A; Oyama T
    Agressologie; 1971; 12(4):283-9. PubMed ID: 4257045
    [No Abstract]   [Full Text] [Related]  

  • 68. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influence of renal and hepatic function on pharmacodynamics and pharmacokinetics of non-depolarizing muscle relaxants.
    Booij LH
    Pharm Weekbl Sci; 1987 Apr; 9(2):56-60. PubMed ID: 2954027
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sugammadex: a selective relaxant binding agent for reversal of neuromuscular block.
    Hogg RM; Mirakhur RK
    Expert Rev Neurother; 2009 May; 9(5):599-608. PubMed ID: 19402771
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A clinical study of serum magnesium concentrations during anaesthesia and cardiopulmonary bypass.
    Calverley RK; Jenkins LC; Griffiths J
    Can Anaesth Soc J; 1973 Jul; 20(4):499-518. PubMed ID: 4268770
    [No Abstract]   [Full Text] [Related]  

  • 72. Pharmacological characteristics of the inhibition of nondepolarizing neuromuscular blocking agents at human adult muscle nicotinic acetylcholine receptor.
    Jonsson Fagerlund M; Dabrowski M; Eriksson LI
    Anesthesiology; 2009 Jun; 110(6):1244-52. PubMed ID: 19417616
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Skeletal muscle relaxants.
    See S; Ginzburg R
    Pharmacotherapy; 2008 Feb; 28(2):207-13. PubMed ID: 18225966
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Basic caused for change of acid-base equilibrium during neurosurgery].
    Shcherbakova LS; Guliaev GV; Solomonik VZ; Atabaev MM
    Vestn Akad Med Nauk SSSR; 1968; 23(10):78-83. PubMed ID: 4243554
    [No Abstract]   [Full Text] [Related]  

  • 76. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Interaction of non-depolarizing muscle relaxants with halothane in rabbits].
    Amaki Y; Uchida M; Otaka M; Kobayashi K
    Masui; 1973 Apr; 22(4):339-43. PubMed ID: 4269820
    [No Abstract]   [Full Text] [Related]  

  • 78. Clinical limitations of acetylcholinesterase antagonists.
    Caldwell JE
    J Crit Care; 2009 Mar; 24(1):21-8. PubMed ID: 19272535
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Resistance to depolarizing relaxants after prior administration of a nondepolarizing relaxant.
    Book WJ; Eisenkraft JB
    Anesth Analg; 1994 Mar; 78(3):611-2. PubMed ID: 8109798
    [No Abstract]   [Full Text] [Related]  

  • 80. Molecular modifications and modulation of adverse actions of muscle relaxants in anesthesiology.
    Cavallito CJ; Foldes FF
    Drug Metab Rev; 1984; 15(3):591-618. PubMed ID: 6092028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.